Search Results 491-500 of 19215 for hemoglobin

  1. A Databank Study of Molecular Circulatory Biomarkers in Non-localized Renal and Testicular Cancer Patients - Mayo Clinic

    Subjects with hemoglobin; Subjects with a previous history of known second non-GU malignancy in the past five years. Participating Mayo Clinic locations.

  2. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

    Adequate bone marrow, hepatic, renal and coagulation function as defined by the following: Absolute neutrophil count ≥1.5 x 10^9/L, Hemoglobin ≥9.0 g/dL ...

  3. A Study Of CGM In GBM - Mayo Clinic

    Hemoglobin ≥9 g/dL. Serum creatinine ≤1.5 × ULN or creatinine clearance ≥60 mL/min. AST and ALT ≤2.5 × ULN. Total bilirubin ≤1.5 × ULN. Willingness and ...

  4. A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2) - Mayo Clinic

    Hemoglobin < 10g/dL (6.25 mmol/L). v) Pleural or peritoneal serous effusion (irrespective of cell content). vi) Any compressive syndrome (for example, but ...

  5. A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies

    Participation eligibility · Hemoglobin ≥ 9 g/dL, (≥ 8 g/dL for subjects who are transfusion dependent) · Absolute neutrophil count ≥ 1500/mm3 · Platelet count ...

  6. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

    Hemoglobin ≥8.0 g/dL. Absolute neutrophil count (ANC) ≥1000/mm3 (neutropenia due to marrow infiltration may be supported by GCSF). Transfusion and/or ...

  7. Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes - Mayo Clinic

    Hemoglobin A1c > 9%; T2DM, or impaired fasting glucose. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

  8. Dr. Rozalina McCoy Archives - Mayo Clinic News Network

    ... hemoglobin levels ― or HbA1c, which is sometimes referred to as A1C ― is key ... have Type 2 diabetes. Controlling blood sugar and glycosylated hemoglobin levels ...

  9. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    Hemoglobin level ≥ 90 g/L (transfusion permitted). Renal and hepatic function as defined below: Aspartate aminotransferase, alanine aminotransferase, and ...

  10. Clinical trials - Oncology (Medical)

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...